Autori: Tchiehe Guilaine Nchugoua
Naslov | Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents (Article) |
Autori | Beljkas Milan Ruzic Dusan ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Info | FUTURE MEDICINAL CHEMISTRY, (2025), vol. 17 br. 4, str. 393-407 |
Projekat | Ministry of Science, Technological Development and Innovation, Republic of Serbia; University of Belgrade-Faculty of Pharmacy [451- 03-65/2024-03/200161, 451-03-66/2024-03/200161]; Ministry of Science, Technological Development and Innovation, Republic of Serbia; University of Belgrade-Institute for Medical Research [451-03-66/2024-03/200015]; Ministry of Science, Technological Development and Innovation, Republic of Serbia; Institute for Oncology and Radiology of Serbia [451-03-66/2024-03/200043] |
Ispravka | Web of Science Članak Elečas Rang časopisa |
|
Naslov | Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents (Article; Early Access) |
Autori | Beljkas Milan Ruzic Dusan ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Info | FUTURE MEDICINAL CHEMISTRY, (2025), vol. br. , str. - |
Projekat | Ministry of Science, Technological Development and Innovation, Republic of Serbia, through Grant Agreement with University of Belgrade-Faculty of Pharmacy [451- 03-65/2024-03/200161, 451-03-66/2024-03/200161]; Ministry of Science, Technological Development and Innovation, Republic of Serbia, through Grant Agreement with University of Belgrade-Institute for Medical Research [451-03-66/2024-03/200015]; Ministry of Science, Technological Development and Innovation, Republic of Serbia, through Grant Agreement with Institute for Oncology and Radiology of Serbia [451-03-66/2024-03/200043] |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
|